Physician profile
Robert K Thompson
NPI 1780812974
$8,047.54
in general payments reported to CMS, 2019-2025
31 companies · $1,025 in 2025
The $1,025 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $835 · 2020: $346 · 2021: $536 · 2022: $1,078 · 2023: $1,510 · 2024: $2,719 · 2025: $1,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,344 · Travel and Lodging: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,344.33 |
| Travel and Lodging | $909.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,588.97 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Epic, Navitor |
| Edwards Lifesciences Corporation | $1,243.63 | 2019-2025 | Sapien 3 Ultra Resilia, Hemosphere, Evoque |
| Abiomed | $1,228.02 | 2019-2025 | Impella |
| Atricure, INC. | $661.63 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Cvrx, INC. | $303.78 | 2022-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $289.05 | 2019-2025 | Lifevest |
| Angiodynamics, INC. | $250.74 | 2019-2025 | Angiovac |
| Intuitive Surgical, INC. | $184.83 | 2019-2020 | |
| Ethicon US, LLC | $175.50 | 2019-2023 | Vistaseal, Prolene, Echelon Flex |
| Medtronic, INC. | $168.97 | 2023-2025 | Corevalve Evolut R, Invos, Penditure |
| Getinge USA Sales, LLC | $151.86 | 2022-2023 | Vasoview Hemopro 2 |
| Mallinckrodt Enterprises LLC | $133.91 | 2019 | |
| Baxter Healthcare | $120.10 | 2019-2023 | Floseal |
| Clearflow INC. | $91.32 | 2023 | Pleuraflow System With Flowglide |
| Lsi Solutions INC | $61.24 | 2022-2024 | Cor-Knot, Valvevault, Cor Knot |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcym INC | $57.78 | 2022-2023 | Perceval |
| Kci USA, INC. | $44.44 | 2022 | |
| Depuy Synthes Sales INC. | $31.45 | 2025 | Zipfix |
| Artivion, INC. | $29.28 | 2023 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive |
| Terumo Cardiovascular Systems Corporation | $28.66 | 2019-2021 | |
| Biomerieux INC | $23.58 | 2023 | Nephrocheck Liquid Control Kit |
| Biom'Up France Sas | $23.28 | 2020 | |
| Dilon Technologies, INC. | $20.87 | 2024 | Hemoblast Bellows |
| Stryker Corporation | $20.46 | 2019 | |
| La Jolla Pharmaceutical Company | $19.43 | 2024 | Giapreza |
| Galvanize Therapeutics, INC | $18.48 | 2024 | Aliya System |
| Pacira Pharmaceuticals Incorporated | $17.82 | 2021 | |
| Ethicon INC. | $15.99 | 2020 | |
| Aroa Biosurgery Incorporated | $14.97 | 2022 | |
| Zimmer Biomet Holdings, INC. | $13.96 | 2021 | |
| Ironshore Pharmaceuticals INC. | $13.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.